Friday - June 12, 2026

Category Archives: Science

ONNIX Appoints Internationally Recognized Infectious Disease Expert Naomi P. O’Grady, M.D., as Chief Medical Officer

Veteran physician-scientist, former NIH Clinical Center leader brings decades of vascular access, infection prevention & FDA-aligned clinical strategy expertise NASHVILLE, Tenn. – June 9, 2026 – ONNIX Global Inc., a medical technology company focused on advancing catheter care through science-driven innovation, … Continue reading →

Ibogaine by David Dardashti Appoints Whitney Nuckolls as Aftercare Coordinator to Enhance Post-Treatment Patient Support

MIAMI, FL – June 8, 2026 – Ibogaine by David Dardashti, a leading facility specializing in alternative therapies, is proud to announce the appointment of Whitney Nuckolls as its new Aftercare Coordinator. This strategic addition to the clinical team underscores the … Continue reading →

Heartwell STAT Imaging Launches Rapid-Turnaround Stroke and Aneurysm Prevention Screening in Midtown New York City and New Jersey

Heartwell STAT Imaging is the established, trusted rapid cardiac ultrasound imaging practice in Manhattan and New Jersey. Heartwell is a top provider for patients looking for rapid DVT ultrasound, and abdominal aortic ultrasound, and provides same-day appointments with no wait, … Continue reading →

Atrial Fibrillation Pipeline Shows Potential with Active Contributions from 10+ Key Companies | DelveInsight

DelveInsight’s, “Atrial Fibrillation Pipeline Insight, 2026” report provides comprehensive insights about 12+ companies and 15+ pipeline drugs in Atrial Fibrillation pipeline landscape. It covers the Atrial Fibrillation pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Lupus Nephritis Pipeline Accelerates as 35+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “Lupus Nephritis Pipeline Insight 2026” report provides comprehensive insights about 35+ companies and 42+ pipeline drugs in the Lupus Nephritis pipeline landscape. It covers the Lupus Nephritis Pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Niemann-Pick Type Pipeline Gains Momentum: 10+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Niemann Pick C Disease Pipeline Insight, 2026” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Niemann Pick C Disease pipeline landscape. It covers the Niemann-Pick Type pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Migraine Therapeutic Pipeline Witnesses Significant Expansion as 30+ Pharma Companies Compete in Advanced Drug Development | DelveInsight

DelveInsight’s, “Migraine Pipeline Insight 2026” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Migraine pipeline landscape. It covers the Migraine pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Migraine Pipeline Therapeutics … Continue reading →

Obesity Clinical Trial Ecosystem Strengthens with 80+ Companies Driving Next-Gen Oncology Innovations | DelveInsight

DelveInsight’s “Obesity Pipeline Insight 2026” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the obesity pipeline landscape. It covers the Obesity pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Obesity therapeutics … Continue reading →

Chronic Kidney Disease Drug Development Pipeline Expands as 75+ Companies Focus on Novel Mechanisms of Action | DelveInsight

DelveInsight’s, “Chronic Kidney Disease Pipeline Insight 2026” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Chronic Kidney Disease pipeline landscape. It covers the Chronic Kidney Disease pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →